Amendment: SEC Form SC 13G/A filed by Bruker Corporation

11/12/24 9:50:14 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Get the next $BRKR alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.6 BRUKER CORP COMMON STOCK Cusip #116794108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #116794108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 14,221,088 Item 6: 0 Item 7: 14,242,121 Item 8: 0 Item 9: 14,242,121 Item 11: 9.407% Item 12: HC Cusip #116794108 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 14,242,121 Item 8: 0 Item 9: 14,242,121 Item 11: 9.407% Item 12: IN Item 1(a). Name of Issuer: BRUKER CORP Item 1(b). Address of Issuer's Principal Executive Offices: 40 Manning Road Billerica, MA 01821 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 116794108 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 14,242,121 (b) Percent of Class: 9.407% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 14,242,121 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of BRUKER CORP. No one other person's interest in the COMMON STOCK of BRUKER CORP is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Diversifying Solutions LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on November 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of BRUKER CORP at September 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $BRKR alert in real time by email

Recent Analyst Ratings for

$BRKR

Date	Price Target	Rating	Analyst
6/2/2026		Peer Perform	Wolfe Research
12/10/2025	$60.00	Peer Perform → Outperform	Wolfe Research
12/9/2025	$40.00	Sell	Goldman
11/20/2025	$60.00	Buy	Rothschild & Co Redburn
5/22/2025	$40.00	Buy → Neutral	Citigroup
12/19/2024	$72.00	Buy	Guggenheim
12/10/2024	$66.00	Neutral	UBS
12/5/2024	$60.00	Sell → Neutral	Goldman

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Bruker Corporation

11/12/24 9:50:14 AM ET

$BRKR

Biotechnology: Laboratory Analytical Instruments

Industrials

Get the next $BRKR alert in real time by email

Recent Analyst Ratings for

$BRKR

Date	Price Target	Rating	Analyst
6/2/2026		Peer Perform	Wolfe Research
12/10/2025	$60.00	Peer Perform → Outperform	Wolfe Research
12/9/2025	$40.00	Sell	Goldman
11/20/2025	$60.00	Buy	Rothschild & Co Redburn
5/22/2025	$40.00	Buy → Neutral	Citigroup
12/19/2024	$72.00	Buy	Guggenheim
12/10/2024	$66.00	Neutral	UBS
12/5/2024	$60.00	Sell → Neutral	Goldman

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Bruker Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BRKR

Amendment: SEC Form SC 13G/A filed by Bruker Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BRKR

$BRKR
Analyst Ratings

Wolfe Research resumed coverage on Bruker

Bruker upgraded by Wolfe Research with a new price target

Goldman initiated coverage on Bruker with a new price target

$BRKR
Insider Trading

Director Bernard Thierry was granted 2,886 shares (SEC Form 4)

EXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 2,000 shares at a strike of $22.19 and sold $87,800 worth of shares (2,000 units at $43.90) as part of a pre-agreed trading plan (SEC Form 4)

SEC Form 4 filed by Munch Mark

$BRKR
SEC Filings

SEC Form SD filed by Bruker Corporation

Amendment: Bruker Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

Bruker Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

$BRKR
Press Releases

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology

Champalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI

$BRKR
Insider Purchases

PRESIDENT & CEO Laukien Frank H bought $100,043 worth of shares (2,608 units at $38.36), increasing direct ownership by 0.01% to 38,462,171 units (SEC Form 4)

Chief Accounting Officer Bures Thomas bought $23,698 worth of shares (500 units at $47.40), increasing direct ownership by 17% to 3,472 units (SEC Form 4)

PRESIDENT & CEO Laukien Frank H bought $1,018,330 worth of shares (20,000 units at $50.92), increasing direct ownership by 0.05% to 38,459,563 units (SEC Form 4)

$BRKR
Financials

Bruker Reports First Quarter 2026 Financial Results

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

$BRKR
Large Ownership Changes